Both are prescription topical treatments for PCOS-related unwanted facial hair. The difference is what's in the formulation — and what each is designed to do.
Here's the clean breakdown.
Eflornithine is a single-ingredient prescription cream. The active ingredient is Eflornithine 12%, which works by slowing the rate at which hair follicles produce new hair. It's FDA-approved for unwanted facial hair (under the brand name Vaniqa). One mechanism, one ingredient.
HairlessHype is Oana's combination formulation. It contains the same eflornithine, plus two additional active ingredients:
Eflornithine — slows hair growth (the same mechanism as in Eflornithine 12%)
Azelaic Acid — a skincare ingredient that slows keratin production (helping weaken the hair shaft itself), evens skin tone, and reduces inflammation
Metformin — works on local insulin signaling and inflammation in the skin, with a mild anti-androgen effect at the local level
What this means in practice.
- HairlessHype works on more than one mechanism at a time. Slowing growth (eflornithine), weakening the strands themselves (azelaic acid), and addressing inflammation and localized androgen activity (metformin). - For women whose unwanted hair comes alongside PCOS-related skin issues — acne, redness, uneven tone — the combination addresses both pictures with one product.
- Eflornithine 12% is more targeted. If your skin doesn't need azelaic acid's tone-evening or metformin's anti-inflammatory effects — or if you're already using other products for those concerns — Eflornithine 12% gives you the hair-growth-slowing mechanism on its own without the additional ingredients.
- Pricing differs. Combination compounded formulations and single-ingredient products are typically priced differently. See the relevant product page for current pricing.
Your Oana clinician will recommend which is the better fit based on your case — including the pattern of your unwanted hair, your skin condition, and what you've already tried